Future studies will need to focus on the relation between clinical measures of pulmonary function (e.g., P/F), inflammatory response (e.g., CRP), viral load, and hypercoagulability (e.g., D-dimer) and the risk of developing cognitive deficits following hospitalization for COVID-19. This evidence concerns the gene CRP and COVID-19.